Precidian ETFs Trust Novo Nordisk A/S B SharesPrecidian ETFs Trust Novo Nordisk A/S B SharesPrecidian ETFs Trust Novo Nordisk A/S B Shares

Precidian ETFs Trust Novo Nordisk A/S B Shares

No trades
See on Supercharts

Key stats


Assets under management (AUM)
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
Shares outstanding
Expense ratio
0.19%

About Precidian ETFs Trust Novo Nordisk A/S B Shares


Issuer
Precidian Investments LLC
Brand
ADRhedged
Home page
Inception date
Jan 7, 2025
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Management style
Passive
Distributes
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Tax on distributions
Ordinary income
NVOH provides exposure to currency-hedged depositary receipt for Americans interested in investing in Novo Nordisk A/S (B Shares). Investing in the ADR or original shares directly exposes investors currency fluctuations, which impacts returns. ADRhedged products aim to provide a slightly different approach to international investing by focusing on a single international stock and hedging the specific currency risk. It is anticipated that each ETF share will represent one ADR share. In addition, each day a currency hedge contract is marked to the market based on the notional value of the currency hedge contract and the change in the value of the local currency in relation to the US dollar. As a result of the market-to-market payments, the ratio of portfolio securities to shares will vary over time. The objective is to provide the total return performance of the stock in its local market.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
Denmark
Weighting scheme
Single asset
Selection criteria
Single asset

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows